Domain Partners VI, L.P.'s Net Worth

$73.7 Million

Estimate Recalculated Nov 1, 2024 10:04AM EST

Who is Domain Partners VI, L.P.

Domain Partners VI, L.P. has an estimated net worth of $73.7 Million. This is based on reported shares across multiple companies, which include ZOGENIX, INC., CoLucid Pharmaceuticals, Inc., MARINUS PHARMACEUTICALS INC, Aldeyra Therapeutics, Inc., Vanda Pharmaceuticals Inc., Syndax Pharmaceuticals Inc, ALIMERA SCIENCES INC, Ocera Therapeutics, Inc., CADENCE PHARMACEUTICALS INC, Regado Biosciences Inc, Celator Pharmaceuticals Inc, and Somaxon Pharmaceuticals, Inc..

SEC CIK

Domain Partners VI, L.P.'s CIK is 0001298033

Past Insider Trading and Trends

2014 was Domain Partners VI, L.P.'s most active year for acquiring shares with 6 total transactions. Domain Partners VI, L.P.'s most active month to acquire stocks was the month of April. 2014 was Domain Partners VI, L.P.'s most active year for disposing of shares, totalling 12 transactions. Domain Partners VI, L.P.'s most active month to dispose stocks was the month of April. 2010 saw Domain Partners VI, L.P. paying a total of $4,158,308.00 for 4,839,667 shares, this is the most they've acquired in one year. In 2014 Domain Partners VI, L.P. cashed out on 3,816,009 shares for a total of $2,520,908.85, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

CoLucid Pharmaceuticals, Inc.

Investor
Updated Sep 13, 2016
Form 4
-100.00%
-1.94M
Sep 13, 2016
Disposition
Sep 09
Form 4
-7.30%
-153.03K
$8.45
-$1.29M
Aug 03, 2016
1.94M
Sale
Aug 01 - Aug 03
Form 4
-6.67%
-149.76K
$6.96
-$1.04M
May 02, 2016
2.10M
Sale
Apr 28
Form 4
May 11, 2015
2.25M
Options
May 11
Form 3
May 05, 2015
43.67K
Showing 5 results

MARINUS PHARMACEUTICALS INC

Investor
Updated Aug 07, 2014
Form 4
20.40%
419.74K
$8.00
$3.36M
Aug 07, 2014
2.48M
Purchase
Aug 05
Form 3
Jul 31, 2014
Showing 2 results

Aldeyra Therapeutics, Inc.

Investor
Updated May 07, 2014
Form 4
May 07, 2014
1.97M
Options
May 07
Form 4
43.25%
589.41K
$6.58
$136.32
May 05, 2014
1.95M
Options
May 01
Form 3
May 01, 2014
Showing 3 results

Syndax Pharmaceuticals Inc

Investor
Updated Mar 08, 2016
Form 4
Mar 08, 2016
1.74M
Options
Mar 08
Form 3
Mar 02, 2016
Showing 2 results

CADENCE PHARMACEUTICALS INC

Investor
Updated Jan 29, 2013
Form 4/A
-1.88%
-154.55K
$5.43
-$839.30K
Jan 29, 2013
8.06M
Sale
ScheduledJan 24 - Jan 25
Form 3
Oct 24, 2006
Form 3
Oct 24, 2006
Showing 3 results

ALIMERA SCIENCES INC

Investor
Updated Jan 17, 2014
Form 4
-7.63%
-296.76K
$6.39
-$1.90M
Jan 17, 2014
3.59M
Sale
ScheduledJan 15 - Jan 16
Form 4
-0.27%
-10.52K
$5.01
-$52.69K
Jun 24, 2013
3.89M
Sale
ScheduledJun 20
Form 4
-1.40%
-55.28K
$5.39
-$297.83K
Jun 20, 2013
3.90M
Sale
ScheduledJun 18 - Jun 19
Form 4
-3.11%
-126.71K
$5.29
-$669.84K
Jun 18, 2013
3.95M
Sale
ScheduledJun 14 - Jun 17
Form 4
-0.13%
-5.34K
$5.00
-$26.68K
Jun 13, 2013
4.08M
Sale
ScheduledJun 11
Form 4
-1.07%
-44.24K
$4.60
-$203.68K
May 17, 2013
4.09M
Sale
May 15 - May 16
Form 4
-14.49%
-700.00K
Jun 03, 2011
4.13M
Disposition
Jun 02
Form 4
8.49%
378.03K
$11.00
Apr 27, 2010
4.83M
Purchase
Apr 27
Form 3
Apr 21, 2010
Showing 9 results

Ocera Therapeutics, Inc.

Investor
Updated Dec 13, 2017
Form 4
-100.00%
-1.90M
Dec 13, 2017
Disposition
Dec 11
Form 4/A
21.76%
331.87K
$6.03
$2.00M
Jul 31, 2013
1.86M
Purchase
Jul 15
Form 3/A
Jul 31, 2013
1.53M
Form 4
21.20%
331.87K
$6.03
$2.00M
Jul 16, 2013
1.90M
Purchase
Jul 15
Form 3
Jul 16, 2013
1.57M
Showing 5 results

ZOGENIX, INC.

Investor
Updated Dec 01, 2010
Form 4
Dec 01, 2010
9.89K
Options
Nov 29
Form 3
Nov 22, 2010
Showing 2 results

Vanda Pharmaceuticals Inc.

Investor
Updated Dec 13, 2006
Form 4
-22.92%
-581.18K
Dec 13, 2006
1.95M
Disposition
Dec 12
Form 4
-20.00%
-634.00K
Nov 03, 2006
2.54M
Disposition
Nov 03
Form 4
-69.79%
-7.32M
Apr 18, 2006
3.17M
Options
Apr 18
Form 3
Apr 12, 2006
Showing 4 results

Regado Biosciences Inc

Investor
Updated Aug 21, 2013
Form 3
Aug 21, 2013
35.55K
Showing 1 results

Celator Pharmaceuticals Inc

Investor
Updated Jan 15, 2013
Form 3
Jan 15, 2013
2.22M
Showing 1 results

Somaxon Pharmaceuticals, Inc.

Investor
Updated Dec 22, 2006
Form 4
-24.98%
-571.00K
Dec 22, 2006
1.71M
Disposition
Dec 21
Form 4
-19.99%
-571.00K
Sep 14, 2006
2.29M
Disposition
Sep 13
Form 4
-83.33%
-14.28M
Dec 20, 2005
2.86M
Options
Dec 20
Form 3
Dec 14, 2005
Showing 4 results